BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

575 related articles for article (PubMed ID: 30973596)

  • 1. Retinal Nonperfusion Characteristics on Ultra-Widefield Angiography in Eyes With Severe Nonproliferative Diabetic Retinopathy and Proliferative Diabetic Retinopathy.
    Nicholson L; Ramu J; Chan EW; Bainbridge JW; Hykin PG; Talks SJ; Sivaprasad S
    JAMA Ophthalmol; 2019 Jun; 137(6):626-631. PubMed ID: 30973596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanistic Evaluation of Panretinal Photocoagulation Versus Aflibercept in Proliferative Diabetic Retinopathy: CLARITY Substudy.
    Nicholson L; Crosby-Nwaobi R; Vasconcelos JC; Prevost AT; Ramu J; Riddell A; Bainbridge JW; Hykin PG; Sivaprasad S
    Invest Ophthalmol Vis Sci; 2018 Aug; 59(10):4277-4284. PubMed ID: 30372756
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Topographical Response of Retinal Neovascularization to Aflibercept or Panretinal Photocoagulation in Proliferative Diabetic Retinopathy: Post Hoc Analysis of the CLARITY Randomized Clinical Trial.
    Halim S; Nugawela M; Chakravarthy U; Peto T; Madhusudhan S; Lenfestey P; Hamill B; Zheng Y; Parry D; Nicholson L; Greenwood J; Sivaprasad S
    JAMA Ophthalmol; 2021 May; 139(5):501-507. PubMed ID: 33704351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinically Significant Nonperfusion Areas on Widefield OCT Angiography in Diabetic Retinopathy.
    Kawai K; Murakami T; Mori Y; Ishihara K; Dodo Y; Terada N; Nishikawa K; Morino K; Tsujikawa A
    Ophthalmol Sci; 2023 Mar; 3(1):100241. PubMed ID: 36545265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Widefield OCT-Angiography and Fluorescein Angiography Assessments of Nonperfusion in Diabetic Retinopathy and Edema Treated with Anti-Vascular Endothelial Growth Factor.
    Couturier A; Rey PA; Erginay A; Lavia C; Bonnin S; Dupas B; Gaudric A; Tadayoni R
    Ophthalmology; 2019 Dec; 126(12):1685-1694. PubMed ID: 31383483
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Intravitreal Aflibercept With Optical Coherence Tomography Angiography Vessel Density in Patients With Proliferative Diabetic Retinopathy: A Secondary Analysis of a Randomized Clinical Trial.
    Alagorie AR; Nittala MG; Velaga S; Zhou B; Rusakevich AM; Wykoff CC; Sadda SR
    JAMA Ophthalmol; 2020 Aug; 138(8):851-857. PubMed ID: 32584384
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ranibizumab Plus Panretinal Photocoagulation versus Panretinal Photocoagulation Alone for High-Risk Proliferative Diabetic Retinopathy (PROTEUS Study).
    Figueira J; Fletcher E; Massin P; Silva R; Bandello F; Midena E; Varano M; Sivaprasad S; Eleftheriadis H; Menon G; Amaro M; Ayello Scheer S; Creuzot-Garcher C; Nascimento J; Alves D; Nunes S; Lobo C; Cunha-Vaz J;
    Ophthalmology; 2018 May; 125(5):691-700. PubMed ID: 29395119
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interaction Between the Distribution of Diabetic Retinopathy Lesions and the Association of Optical Coherence Tomography Angiography Scans With Diabetic Retinopathy Severity.
    Ashraf M; Sampani K; Rageh A; Silva PS; Aiello LP; Sun JK
    JAMA Ophthalmol; 2020 Dec; 138(12):1291-1297. PubMed ID: 33119083
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characteristics of Retinal Neovascularization in Proliferative Diabetic Retinopathy Imaged by Optical Coherence Tomography Angiography.
    Ishibazawa A; Nagaoka T; Yokota H; Takahashi A; Omae T; Song YS; Takahashi T; Yoshida A
    Invest Ophthalmol Vis Sci; 2016 Nov; 57(14):6247-6255. PubMed ID: 27849310
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diabetic Retinopathy Severity and Peripheral Lesions Are Associated with Nonperfusion on Ultrawide Field Angiography.
    Silva PS; Dela Cruz AJ; Ledesma MG; van Hemert J; Radwan A; Cavallerano JD; Aiello LM; Sun JK; Aiello LP
    Ophthalmology; 2015 Dec; 122(12):2465-72. PubMed ID: 26350546
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The prognostic value of peripheral retinal nonperfusion in diabetic retinopathy using ultra-widefield fluorescein angiography.
    Antaki F; Coussa RG; Mikhail M; Archambault C; Lederer DE
    Graefes Arch Clin Exp Ophthalmol; 2020 Dec; 258(12):2681-2690. PubMed ID: 32676792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retinal Nonperfusion in Proliferative Diabetic Retinopathy Before and After Panretinal Photocoagulation Assessed by Widefield OCT Angiography.
    Russell JF; Al-Khersan H; Shi Y; Scott NL; Hinkle JW; Fan KC; Lyu C; Feuer WJ; Gregori G; Rosenfeld PJ
    Am J Ophthalmol; 2020 May; 213():177-185. PubMed ID: 32006481
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Targeted Retinal Photocoagulation for Diabetic Macular Edema with Peripheral Retinal Nonperfusion: Three-Year Randomized DAVE Trial.
    Brown DM; Ou WC; Wong TP; Kim RY; Croft DE; Wykoff CC;
    Ophthalmology; 2018 May; 125(5):683-690. PubMed ID: 29336896
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantification of Retinal Nonperfusion Associated With Posterior Segment Neovascularization in Diabetic Retinopathy Using Ultra-Widefield Fluorescein Angiography.
    Baxter SL; Ashir A; Nguyen BJ; Nudleman E
    Ophthalmic Surg Lasers Imaging Retina; 2019 Feb; 50(2):86-92. PubMed ID: 30768215
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Topographic distribution of retinal neovascularization in proliferative diabetic retinopathy using ultra-wide field angiography.
    Nidhi V; Verma S; Shaikh N; Azad SV; Chawla R; Venkatesh P; Vohra R; Kumar V
    Indian J Ophthalmol; 2023 Aug; 71(8):3080-3084. PubMed ID: 37530284
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship Between Retinal Fractal Dimension and Nonperfusion in Diabetic Retinopathy on Ultrawide-Field Fluorescein Angiography.
    Fan W; Nittala MG; Fleming A; Robertson G; Uji A; Wykoff CC; Brown DM; van Hemert J; Ip M; Wang K; Falavarjani KG; Singer M; Sagong M; Sadda SR
    Am J Ophthalmol; 2020 Jan; 209():99-106. PubMed ID: 31472160
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors Associated with Worsening Proliferative Diabetic Retinopathy in Eyes Treated with Panretinal Photocoagulation or Ranibizumab.
    Bressler SB; Beaulieu WT; Glassman AR; Gross JG; Jampol LM; Melia M; Peters MA; Rauser ME;
    Ophthalmology; 2017 Apr; 124(4):431-439. PubMed ID: 28161147
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantification of Retinal Nonperfusion and Neovascularization With Ultrawidefield Fluorescein Angiography in Patients With Diabetes and Associated Characteristics of Advanced Disease.
    Yu G; Aaberg MT; Patel TP; Iyengar RS; Powell C; Tran A; Miranda C; Young E; Demetriou K; Devisetty L; Paulus YM
    JAMA Ophthalmol; 2020 Jun; 138(6):680-688. PubMed ID: 32352506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Retinal function in eyes with proliferative diabetic retinopathy treated with intravitreal ranibizumab and multispot laser panretinal photocoagulation.
    Messias K; Barroso RM; Jorge R; Messias A
    Doc Ophthalmol; 2018 Oct; 137(2):121-129. PubMed ID: 30209775
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of Nonperfusion and Neovascularization on Ultrawide-Field Fluorescein Angiography in Proliferative Diabetic Retinopathy (RECOVERY Study): Report 1.
    Fan W; Nittala MG; Velaga SB; Hirano T; Wykoff CC; Ip M; Lampen SIR; van Hemert J; Fleming A; Verhoek M; Sadda SR
    Am J Ophthalmol; 2019 Oct; 206():154-160. PubMed ID: 31078541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.